Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Newron Plans Extended Phase IIb Trial Of Safinamide In Parkinson's

Jan. 15, 2003

By Cormac Sheridan

Elan Names Wall Street Veteran As CEO To Lead Divestiture Plan

Jan. 8, 2003

By Cormac Sheridan

Elan Names Wall Street Veteran As CEO To Lead Divestiture Plan

Jan. 8, 2003

By Cormac Sheridan

Axovan, Biolipox Collaborate On GPCR-Binding Drug Discover

Jan. 1, 2003

By Cormac Sheridan

Axovan, Biolipox Collaborate On GPCR-Binding Drug Discover

Jan. 1, 2003

By Cormac Sheridan

Berna Biotech, Samsung Win Vietnamese Vaccines Project

Dec. 25, 2002

By Cormac Sheridan

Berna Biotech, Samsung Win Vietnamese Vaccines Project

Dec. 25, 2002

By Cormac Sheridan

Pharmexa Moving Pharmaccine For Cancer Into Phase II Studies

Dec. 18, 2002

By Cormac Sheridan

Pharmexa Moving Pharmaccine For Cancer Into Phase II Studies

Dec. 18, 2002

By Cormac Sheridan

Enkam Finalizing First Round, Planning For First Clinical Trial

Dec. 11, 2002

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...